Tutor Perini Announces Conference Call to Discuss First Quarter 2024 Results
Business Wire
LOS ANGELES--(BUSINESS WIRE)--Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty..
LOS ANGELES--(BUSINESS WIRE)--Tutor Perini Corporation (NYSE: TPC) (the “Company”), a leading civil, building and specialty..
The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in..
The clinical trial for SCI-210 will be conducted in Israel, after which the company aims to move forward with the commercialization..